OLMA Olema Pharmaceuticals, Inc.

7.940USD+0.25%Mkt Cap: 694.73M $P/E: —

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant…

Key Statistics

Company
Market Cap694.73M USD
Enterprise Value235.57M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-162.45M USD
Revenue/Share—
Last Price7.940 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees150
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.00
PEG—
EV/EBITDA-1.07
EV/Revenue—
P/S—
P/B1.61
EPS (TTM)-2.04
EPS (Forward)-2.64
52W Range
6.6504% of range36.26
52W High36.26 USD
52W Low6.650 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-33.95%
ROA-30.45%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-146.72M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-12.82%
Net Debt-457.41M USD
Net Debt/EBITDA2.07
Balance Sheet
Debt/Equity0.01
Current Ratio8.86
Quick Ratio8.76
Book Value/Sh4.92 USD
Cash/Share5.27 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)36.50 USD
Upside (mean)+359.7%
Target Range16.00 USD – 59.00 USD
16.00+359.7% to mean59.00
# Analysts10
Ownership
Shares Out.87.50M
Float59.24M
Insiders1.76%
Institutions119.63%
Short Interest
Short Ratio17.2d
Short % Float22.31%
Short % Out.18.36%
Shares Short16.07M
Short (prev mo.)15.81M
Technical
SMA 5010.39 (-23.6%)
SMA 20015.94 (-50.2%)
Beta2.01
S&P 52W Chg16.45%
Avg Vol (30d)1.12M
Avg Vol (10d)1.27M
Technical Indicators
RSI (14)27.0
MACD-0.7363
MACD Signal-0.6464
MACD Hist.-0.0899
BB Upper11.31 USD
BB Middle9.277 USD
BB Lower7.247 USD
BB Width43.77%
ATR (14)0.5189 USD
Vol Ratio (20d)0.66x